Left main and bifurcation stenting

Coronary artery bypass graft (CABG) is considered as the gold standard treatment of unprotected left main coronary artery disease. Over the last 10 years, improvement in stent technology and operators experience explained the increased number of reports on the results of percutaneous coronary interventions for the treatment of left main (LM) coronary artery lesion particularly in the distal part of the trunk. Patient selection for bifurcation stenting is fundamental and directly impacts the clinical outcome. Many trials are conducted using bifurcated stenting technology. Further randomized trials must be conducted to precise the indications of both techniques (CABG-PCI) of revascularization in the treatment of LM disease.